ESSO Course on Peritoneal Surface Malignancy
|
|
- Myrtle Parker
- 8 years ago
- Views:
Transcription
1 ESSO Course on Peritoneal Surface Malignancy In partnership with The Christie School of Oncology October 2015 MANCHESTER (UK)
2 ESSO Course on Peritoneal Surface Malignancy Chair: Sarah O Dwyer, The Christie NHS Foundation Trust, Manchester, UK Co-Chair: Santiago González-Moreno, MD Anderson Cancer Center, Madrid, SP Faculty Members Thomas Bacheitner- Hofmann, Medical University of Vienna, AT Norman Carr, Basingstoke and North Hampshire Hospital, Basingstoke, UK Tom Cecil, Basingstoke and North Hampshire Hospital, Basingstoke, UK Marcello Deraco, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT Charles Honoré, Institut de Cancérologie Gustave Roussy, Villejuif, FR Brendan Moran, Basingstoke and North Hampshire Hospital, Basingstoke, UK Pompiliu Piso, St. John of God Hospital, Regensburg, DE Beate Rau,Charité Campus Mitte, Berlin, DE Josefin Segelman, Karolinska Institut, Solna, Stockholm, SE Paul H Sugarbaker, Washington Cancer Center, Washington, USA Kurt Van der Speeten, Ziekenhuis Oost-Limburg, Genk, BE Vic Verwaal, The Netherlands Cancer Institute, Amsterdam, NL Willemien van Driel, Netherlands Cancer Institute, Amsterdam, NL Local Faculty Omar Aziz Rahul Deshpande Paul Fulford Vidya Kasipandian Rohit Kochhar Andrew Renehan Mark Saunders Chelliah Selvasekar Malcolm Wilson
3 Aim of the course A comprehensive workshop on Peritoneal Surface Malignancies addressing current treatments for specific tumour groups and future challenges for developing services in different health care settings. The course will focus on delivering evidence-based clinical practice and achieving quality assured outcomes for patients undergoing abdominal and pelvic cytoreductive surgery and intraperitoneal chemotherapy. Topics covered Neoplasia of the appendix: pathology, diagnosis and clinical pathways Peritoneal Surface Malignancies: outcomes for colorectal, ovarian, gastric cancers and mesothelioma Surgical techniques: tips and tricks to achieve complete cytoreduction Intraperitoneal chemotherapy: why, what, who and how Setting up a service: challenges and opportunities Ideal Course candidates Consultant Surgeons/gynaecologists/oncologists Senior residents/fellows surgery/gynaecology/oncology Senior Nurse Practitioners in PSM/oncology Educational methods Live surgical session with interactive discussion Video sessions/workshops on surgical technique and HIPEC Plenary lectures MDT case management Interactive voting on key topics Course Venue The Christie NHS Foundation Trust Wilmslow Road Manchester, M20 4BX United Kingdom
4 Course coordination Ana Galán European Society of Surgical Oncology (ESSO) . Application Procedure Please go to (education/projects & courses) to complete your application and apply for the course. Participation fee The participation fee is 650 for ESSO members and 800 for non-members. It includes registration for the 2-day course,coffee breaks and lunches and a social dinner. Accreditation An application for accreditation has been submitted to the European Accreditation Council for CME (EACCME) of the European Union of Medical Specialists (UEMS).
5 Programme Thursday 08 October Welcome 08:15-08:30 Aims and objectives; global guidelines S. O Dwyer, S.González-Moreno Generic challenges in PSM Service delivery for PSM Moderators: B. Moran, P. Piso 08:30-08:45 The European picture: reference centres and networks S.González-Moreno 08:45-09:00 Setting up a service: challenges and opportunities T. Bacheitner - Hofman 09:00-09:05 Discussion 09:05-09:35 Imaging for PSM: what the MDT should look for R. Kochar 09:35-09:40 Discussion 09:40-10:10 Keynote address: Evidence base and principles of management of peritoneal metastases P. Sugarbaker Chemotherapy Moderators: A. Renehan, V. Verwaal 10:10-10:25 HIPEC: overview of current regimes K. Van der Speeten 10:25-10:30 Can we reach a consensus: voting 10:30-10:40 Systemic chemotherapy: when how and what M. Saunders 10:40-10:50 EPIC: when how and what K. Van der Speeten 10:50-10:55 Can we reach a consensus: voting 10:55-11:15 Coffee break Perioperative support: tips and tricks Moderators: P. Fulford, T.B- Hofmann 11:15-11:30 Anaesthesia, critical care and pain management V. Kasipandian 11:30-11:45 Nutrition and enhanced recovery O. Aziz 11:45-12:00 Complications: how to avoid them B. Rau 12:00-12:15 Standardised recording of morbidity and mortality A. Reneham
6 12:15-12:30 Recommendations for follow up: why, who and for how long? T. Cecil 12:30-12:45 Discussion/voting Lunch Surgical techniques: tips and tricks Moderators: M. Wilson, S.G. Moreno 13:30-14:30 RUQ, R. Deshpande LUQ, P. Piso Central abdomen, M. Deraco Pelvis, T. Cecil MAS, C. Selvaseker HIPEC, K. Van der Speeten 14:30-14:45 Discussion 14:45-15:00 Coffee break Parallel sessions 15:00-17:00 Surgical techniques workshops/videos MDT case discussions Pathology workshop Nursing workshop Friday 09 October Disease specific challenges in PSM Appendix neoplasia Moderators: P. Fulford, M. Deraco 08:30-08:55 Keynote address: Concensus on the classification of appendix neoplasia N. Carr 08:55-09:00 Discussion 09:00-09:15 PMP Presentation and outcomes M. Wilson 09:15-09:30 Management of recurrence B.Moran 09:30-09:40 Discussion Surgery Moderators: S. O Dwyer, C. Selvaseker, A. Renehan, P. Fulford 09:40-10:15 Case Presentation and Live Surgery Coffee break
7 Colon and rectum Moderator: P. Piso 10:45-11:00 Patient selection and outcomes C. Honore 11:00-11:10 Selecting high risk patients J. Segelman 11:10-11:25 Future opportunities for CRS in colorectal cancer P.Sugarbaker 11:25-11:30 Discussion Surgery 11:30-12:00 Live surgery/ case discusion Mesothelioma Moderator: T. Cecil 12:00-12:40 Keynote address: Current and Future directions for the treatment of Peritoneal Mesothelioma M. Deraco 12:40-12:45 Discussion 12:45-13:45 Lunch (live surgery continues during lunch break) Gastric Cancer Moderator: C. Honore 13:45-14:10 Patient selection outcomes and future potential P. Piso 14:10-14:15 Discussion Surgery 14:15-14:30 Live surgery Ovarian Cancer Moderator: V. Verwaal 14:30-15:00 Keynote adress: Evidence base and recommendations for the treatment of ovarian peritoneal metastasis W. van Driel Discussion Palliative treatment for PSM Moderator: B.Rau 15:05-15:20 Strategies and outcomes from palliation K. Van der Speeten 15:20-15:25 Discussion 15:25-15:50 MDT Case discussions/live surgery update 15:50-16:00 Summary and Close
8 ESSO is grateful for the continuous support of its corporate sponsors European Society of Surgical Oncology (ESSO) Avenue E. Mounier 83 B 1200 Brussels Tel: +32 (0) Fax : +32 (0) info@essoweb.org Website :
2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma
2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma Focus on stage III and IV melanoma In partnership with the Society of Surgical Oncology (SSO) 12-14 November 2015 ATHENS (GR)
More informationEnhanced Recovery after Surgery: Benefits, Challenges and Solutions for Implementation
Enhanced Recovery after Surgery: Benefits, Challenges and Solutions for Implementation 06-07 November 2015 MILAN (IT) IN PARTNERSHIP WITH Enhanced Recovery after Surgery: Benefits, Challenges and Solutions
More informationHighly Specialised Services. Peritoneal Oncology Service. Report September 2015
Highly Specialised Services Peritoneal Oncology Service Report September 2015 The Christie NHS Foundation Trust Wilmslow Road Withington Manchester M20 4BX http://www.christie.nhs.uk/our-services/colorectal-and-peritoneal-oncology-centre
More informationESSO Advanced Course on Oncoplastic Breast Surgery 16-18 June 2016
ESSO Advanced Course on Oncoplastic Breast Surgery 16-18 June 2016 BUDAPEST (HU) ESSO Advanced Course on Oncoplastic Breast Surgery Course directors Tibor Kovacs, Guy s and St. Thomas NHS Foundation Trust,
More informationLuis D. Carcorze Soto, MD PGY-3
Luis D. Carcorze Soto, MD PGY-3 Peritoneal Surface Malignancies Peritoneum Patient Selection Operative Technique HIPEC EPIC Primary: Primary Peritoneal Carcinoma Malignant Peritoneal Mesothelioma Metastatic:
More informationFaculty. 1 of 6 4/20/2016 12:14 PM. Home Register Program Abstracts Workshops Hotel
10th International Congress on Peritoneal Surface Malignancies - 1 of 6 4/20/2016 12:14 PM Home Register Program Abstracts Workshops Hotel Home Registration Program Meet the Professor Breakfast Sessions
More informationPeritoneal Surface Malignancies. Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA
Peritoneal Surface Malignancies Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA Cancer dissemination routes Hematogenous metastases Lymphatic metastases Implants on peritoneal surfaces Surgically
More informationIntraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD
Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD KCHC 8/29/13 52 y.o. F presented with severe pain in the right back and right flank, sharp, 8 out of 10, for 7 days.
More informationCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future Mazin Al-kasspooles, MD Associate Professor of Surgery Division of Surgical Oncology Director, Regional Therapy
More information2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Wednesday Oct 7th, 2015 Congress Center (Hörsaal 1 3) Marien Hospital Herne Accreditation by the Medical Chamber
More informationChirurgia Avanzata Del Carcinoma Ovarico Nuove Strategie A Confronto Ovarian Cancer Advanced Surgery New Strategies in Comparison
Peritoneal dissection and intraperitoneal chemotherapy under hyperthermic conditions. If you select the right patients long-term survival can be achieved. Chirurgia Avanzata Del Carcinoma Ovarico Nuove
More informationONCOLOGY NURSING 7 TH ESO-EONS MASTERCLASS IN. 8-13 March 2014 Ermatingen (Lake Constance) Switzerland MASTERCLASS
MASTERCLASS Photo: Turm by Stephan Balkenhol - A Sculpture for Wolfsberg Photographer: Ralph Feiner, Architekturfotografie, Malans 7 TH ESO-EONS MASTERCLASS IN ONCOLOGY NURSING 8-13 March 2014 Ermatingen
More informationPseudomyxoma Peritonei Where are we in 2014?
Pseudomyxoma Peritonei Where are we in 2014? Santiago González-Moreno, MD, PhD Head, Department of GI Surgical Oncology Peritoneal Surface Oncology Program Medical Director * * * * * * * * * * * * French
More informationCytoreduction and hyperthermic intraperitoneal chemotherapy for the treatment of pseudomyxoma
Medical Policy Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pseudomyxoma Peritonei and Peritoneal Carcinomatosis of Gastrointestinal Origin, and Peritoneal Mesothelioma
More information15th Colorectal Day Programme
15th Colorectal Day Programme 7TH OF JUNE 2016 AARHUS UNIVERSITY HOSPITAL, SKEJBY ENTRANCE 6, AUDITORIUM A www.crd.auh.dk Fotograf: Kristian Bang, AUH Dear friends and colleagues It is our pleasure to
More informationGOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA. 17-18 June 2010 Golnik, Slovenia. Chair: T. Cufer, SI - G.L. Ceresoli, IT
ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA 17-18 June 2010 Golnik, Slovenia Chair: T. Cufer, SI - G.L. Ceresoli, IT AIM OF THE COURSE The incidence
More informationAdvances in Surgical Oncology
3-4 December 2015 Advances in Surgical Oncology 3 rd International Conference of the Medical University of Lublin 10 th anniversary of first Intraoperative Radiotherapy in Lublin 1 Scientific Chairman
More informationHow To Teach A Patient To Live With A Tumour
RECTAL CANCER WHEN TO OPERATE Operative Treatment Strategies... From Minimal to Maximal Champalimaud Foundation Lisbon, Portugal 7 th - 8 th November 2014 Organisation - Champalimaud Foundation Amjad Parvaiz
More informationQuick Facts about Appendix Cancer
Quick Facts about Appendix Cancer What is the appendix? The appendix is a pouch-like tube attached to the first part of the large intestine (cecum). The appendix is about 10 centimetres long and has no
More informationInternational Symposium on Malignant Pleural Mesothelioma
International Symposium on Malignant Pleural Mesothelioma LONDON 2015 Friday 6th & Saturday 7th November 2015 Jumeirah Carlton Tower Hotel Cadogan Place Knightsbridge London SW1X 9PY United Kingdom Dear
More informationPerioperative Intraperitoneal Chemotherapy. Annals of surgical oncology 17.9 (2010): 2370 7. Web. 17 Jan. 2015.
Alexander, H Richard et al. Treatment Factors Associated with Long-Term Survival after Cytoreductive Surgery and Regional Chemotherapy for Patients with Malignant Peritoneal Mesothelioma. Surgery 153.6
More informationRachel E. Kirby, Jing Zhao, Terence Chua, Winston Liauw and David L. Morris *
Send Orders for Reprints to reprints@benthamscience.net The Open Surgical Oncology Journal, 2014, 5, 1-5 1 Open Access Avoidance of Early Post-Operative Intraperitoneal Chemotherapy (EPIC) Following Peritonectomy
More informationINTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC)
MEDICAL POLICY INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) Policy Number: CS141.A Effective Date: September 1, 2015 Table of Contents COVERAGE RATIONALE DEFINITIONS... APPLICABLE CODES..
More information1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
More informationComments: Policy Accepted during 2013 Annual Review with no changes.
Health Plan Coverage Policy ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 09/18/2013 Title: Cytoreduction Surgery with Hyperthermic Intraperitoneal Chemotherapy Comments: Policy
More informationELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium
More informationVillejuif, Paris, France
SCIENTIFIC PROGRAMME 2014 Preceptorships in oncology Aim This live educational preceptorship aims to highlight the crucial role of the multidisciplinary approach in diagnosis, treatment and management
More informationESO INSIDE TRACK CONFERENCE. 4 th FAMILIAL CANCER CONFERENCE. 7-8 June 2010 Madrid, Spain. Chair: J. Benítez, ES - H. Vasen, NL MADRID 07/06/10
ESO INSIDE TRACK CONFERENCE MADRID 07/06/10 4 th FAMILIAL CANCER CONFERENCE 7-8 June 2010 Madrid, Spain Chair: J. Benítez, ES - H. Vasen, NL APPLICATION AND ABSTRACT SUBMISSION Poster abstract deadline
More informationCorporate Medical Policy
Corporate Medical Policy Hyperthermic Intraperitoneal Chemotherapy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hyperthermic_intraperitoneal_chemotherapy 5/19/2005 3/2016 3/2017
More informationCytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly
Huang et al. World Journal of Surgical Oncology (2015) 13:262 DOI 10.1186/s12957-015-0682-7 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Cytoreductive surgery and perioperative intraperitoneal chemotherapy
More informationCLINICAL ONCOLOGY MASTERCLASS IN. 25-29 April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME
ESO - LATIN-AMERICAN PROGRAMME MASTERCLASS IN CLINICAL ONCOLOGY 25-29 April 2015 São Paulo, Brazil Chairs: N. Pavlidis, GR - R.A. Stahel, CH Scientific Co-ordinators: M. Aapro, CH - F. Cardoso, PT FOREWORD
More informationNational Bowel Cancer Audit Report 2008 Public and Executive Summary
National Bowel Cancer Audit Report 2008 Public and Executive Summary Prepared in association with: Healthcare Quality Improvement Partnership HQIP Association of Coloproctology of Great Britain and Ireland
More informationESO INSIDE TRACK CONFERENCE. 4 th FAMILIAL CANCER CONFERENCE. 7-8 June 2010 Madrid, Spain. Chair: J. Benítez, ES - H. Vasen, NL MADRID 07/06/10
ESO INSIDE TRACK CONFERENCE MADRID 07/06/10 4 th FAMILIAL CANCER CONFERENCE 7-8 June 2010 Madrid, Spain Chair: J. Benítez, ES - H. Vasen, NL APPLICATION AND ABSTRACT SUBMISSION Poster abstract deadline
More informationClinical Commissioning Policy: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma
Clinical Commissioning Policy: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma Reference: NHS England B03/P/a 1 Information Reader Box (IRB) to be inserted
More informationDie multimodale Behandlung der Peritonealkarzinose
Die multimodale Behandlung der Peritonealkarzinose Pompiliu Piso Chirurgische Klinik der Universität Regensburg 80 Mio Inhabitans 70.000 new cases CRC/year. Henriettenstiftung Hannover Medizinische Hochschule
More informationPopulation Pharmacokinetics and Pharmacodynamics of Cisplatinum During Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure
Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure Eddy Cotte, Brigitte Tranchand, Annie-Claude Beaujard, François-Noël
More informationCANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES
CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES Coordinator: Alex Kartheuser (Colorectal Surgery, Cliniques universitaires St-Luc, UCL) Authors
More informationSUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN
SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN Paediatric Hepatology: from basic science to daily practice June 13-16th, 2012 Bordeaux, France Program European Society for Paediatric Gastroenterology,
More informationBOWEL CANCER. The doctor has explained that you have a growth or tumour, in your bowel or rectum and could be cancer.
Patient and Carer Information BOWEL CANCER Please read this leaflet carefully. It is important that you take note of any instructions or advice given. If you have any questions or problems that are not
More informationSKIN MELANOMA. 27-28 September 2006, Istanbul, TR
ESO SEMINARES SKIN MELANOMA 27-28 September 2006, Istanbul, TR Chair: N. Cascinelli, IT - A.M.M. Eggermont, NL - S. Kurul, TR Host Chair: M. Erkisi, TR - F. Tas, TR Co-ordinators: G. Demir, TR - H. Camlica,
More informationTEACH Summer School Cascais, Portugal 3-7 July, 2016. Training and Education for Advanced Clinicians and HCPs in Personalised Medicine
TEACH Summer School Cascais, Portugal 3-7 July, 2016 Training and Education for Advanced Clinicians and HCPs in Personalised Medicine TEACH Summer School Cascais, Portugal 3-7 July, 2016 Objectives There
More informationClinical Commissioning Policy: Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma
Clinical Commissioning Policy: Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma Reference: NHS England A08/P/c 2 NHS England INFORMATION READER BOX Directorate
More informationScientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Luca Gianni Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy Ana Maria Gonzalez-Angulo M.D. Anderson Cancer
More informationREPORT ON STOMA SERVICE AND PRACTICE. MM / YY to MM / YY. Name: Title: Centre:
REPORT ON STOMA SERVICE AND PRACTICE MM / YY to MM / YY Name: Title: Centre: 1 Contents 1.0 Introduction 2.0 Aims of the Stoma Care Service 3.0 Clinical Activity 4.0 Cost Saving Measures 5.0 Education
More informationH. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md
Major Advances in Cancer Prevention, Diagnosis and Treatment~ Why Mesothelioma Leads the Way H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland
More informationNational Medical Policy
National Medical Policy Subject: Policy Number: Intraperitoneal Hyperthermic Chemotherapy for Abdominopelvic Cancers NMP346 Effective Date*: June 2007 Updated: November 2014 This National Medical Policy
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): July 22, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationMonitoring Clinical Stage to Improve Care
Monitoring Clinical Stage to Improve Care Stephen Dreyer, MD, FACS Cancer Liaison State Chair Nebraska Fremont, NE M. Asa Carter, CTR Manager, Accreditation and Standards American College of Surgeons Chicago,
More informationColumbia University Mesothelioma Applied Research Foundation - 2009 - www.curemeso.org. Mesothelioma Center www.mesocenter.org
Columbia University Mesothelioma Center www.mesocenter.org Multimodal clinical trials, treatment (surgery, radiation, chemotherapy) Peritoneal mesothelioma program Immunotherapy translational, experimental
More informationCOMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER
COMMISSIONING for ULTRA-RADICAL SURGERY in ADVANCED OVARIAN CANCER WHY THIS MUST HAPPEN PERSPECTIVE COMMISSIONING FOR WHO, FOR WHAT? Biological Basis Surgical Basis International and national standards
More informationHow To Manage A Cancer Oncology Clinic
GYNAECOLOGICAL ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY Version 3 Policy agreed Sept 2009 (updated Jan/Feb 2013) Agreed by: SCAN gynae group 2009 Update agreed SCAN gynae group May
More informationHow To Treat Mesothelioma
Mesothelioma in the UK Liz Darlison Mesothelioma UK The National Macmillan Mesothelioma Resource Centre June 2010 Mesothelioma Applied Research Foundation - 2010 www.curemeso.org Contents Size of Mesothelioma
More informationCANCER IN THE ELDERLY
ESO ADVANCED COURSES AND SEMINARS In collaboration with: CANCER IN THE ELDERLY 5-6 May 2006, Maastricht Chair: R.A. Audisio, UK - J.W.W. Coebergh, NL Under the auspices of: FRIDAY 5 MAY 08:15 Registration
More informationGRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT 1) TOPIC OF THE EVENT MALIGNANT PLEURAL DISEASE 2) SUGGESTED TITLE : Approach to Pleural Cancer: State-of-the-Art 3) TYPE OF EVENT Course Native
More informationIN MANY PATIENTS WITH ABDOMINAL OR PELVIC MALIGNANCIES, surgical treatment
Sugarbaker, Cancerología 3 (2008): 119-124 1 Washington Cancer Institute, Washington, DC, USA Overview of Peritoneal Carcinomatosis Paul H. Sugarbaker 1 Abstract IN MANY PATIENTS WITH ABDOMINAL OR PELVIC
More informationMulti-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma
Original article Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma T. C. Chua 1,T.D.Yan 1,2, M. Deraco 3,O.Glehen 4,B.J.Moran 5 and P. H. Sugarbaker 6,onbehalf
More informationInformation for Men Diagnosed with Testicular Cancer
Patient Information Service Information for Men Diagnosed with Testicular Cancer Bristol Haematology and Oncology Centre Bristol Testicular Cancer Service Patient Information is supported by September
More informationPeritoneal Carcinosis
Peritoneal Carcinosis What is it and how to cure it Peritoneum Peritoneum is a thin and transparent membrane that covers the internal part of the abdominal and pelvic cavity and all the viscera contained
More informationFact sheet 10. Borderline ovarian tumours. The difficult cases. What is borderline ovarian cancer (BOC)?
For this reason, some doctors prefer the term borderline ovarian tumour rather than borderline ovarian cancer. Fact sheet 10 Borderline ovarian tumours We, Ovacome, are a support network for people affected
More informationProgram Chairs: Robert W. Holloway, MD and Martin Martino, MD Speakers and times are subject to change
FRIDAY, FEBRUARY 20, 2015 Program Chairs: and Martin Martino, MD Speakers and times are subject to change 6:00 a.m. 6:00 p.m. Registration/Information Desk /L Foyer 6:00 a.m. 6:00 p.m. Speaker Ready Area
More informationScientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico
More informationGentofte Workshop 2013
Gentofte Workshop 2013 Copenhagen University Hospital Gentofte, Denmark Basic course in CT guided lung biopsy 13th and 14th of June, 2013 Dear colleagues It is a pleasure to invite you to our fourth basic
More informationDepartments of Nuclear Medicine, Surgery, and Endocrinology University of Ulm
4 th Würzburg Summer School of Thyroid Cancer Management A training course on basics, diagnosis and therapy of differentiated thyroid tumours under the auspices of the European Association of Nuclear Medicine
More informationLaparoscopic Hyperthermic Intraperitoneal Chemotherapy: Indications, Aims, and Results: A Systematic Review of the Literature
Ann Surg Oncol DOI 10.1245/s10434-012-2360-0 ORIGINAL ARTICLE REVIEW ARTICLE Laparoscopic Hyperthermic Intra Chemotherapy: Indications, Aims, and Results: A Systematic Review of the Literature Enrico Facchiano,
More informationFRIDAY MAY 9, 2014. Seattle, WA
FRIDAY MAY 9, 2014 ORIN SMITH AUDITORIUM UW Medicine south lake union campus Seattle, WA Course Description This symposium is designed to bring state of the art information on current research and clinical
More informationEMRI ERASMUS COURSE ON MAGNETIC RESONANCE. MRI Abdominal Module
EMRI ERASMUS COURSE ON MAGNETIC RESONANCE MRI Abdominal Module September, 23-26, 2015 Coimbra, Portugal LOCAL ORGANIZERS F Caseiro-Alves L Curvo-Semedo Dear Colleagues: It is our pleasure to receive you
More informationINTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS
INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS Description of Treatment A major difficulty in treating
More informationTreating Mesothelioma - A Quick Guide
Treating Mesothelioma - A Quick Guide Contents This is a brief summary of the information on Treating mesothelioma from CancerHelp UK. You will find more detailed information on the website. In this information
More informationJ Clin Oncol 27:6237-6242. 2009 by American Society of Clinical Oncology INTRODUCTION
VOLUME 27 NUMBER 36 DECEMBER 20 2009 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma:
More informationOVARIAN CANCER TREATMENT
OVARIAN CANCER TREATMENT Cancer Care Pathways Directorate Tailored Information in Cancer Care (TICC) Sir Anthony Mamo Oncology Centre National Cancer Plan May 2015 Contents About this booklet 1 The Ovaries
More informationRichmond meets Salzburg
Richmond meets Salzburg A Foregut and Bariatric Surgery Symposium Thursday 10 th till Friday 11 th of December 2015 Salzburg Congress 122 nd educational meeting in cooperation with the Austrian Society
More informationGentofte Workshop. Gentofte. Hospital 10/2012. University. Training Centre
Gentofte Workshop 10/2012 Gentofte University Hospital EUS and EBUS Training Centre Basic course in interventional endosonography for lung diseases 1st and 2nd October 2012 Dear colleagues, It is a pleasure
More informationMapping quality assurance approaches in Europe
Mapping quality assurance approaches in Europe Reinhard Busse (with Helena Legido-Quigley & Martin McKee) Professor of Health Care Management, Technische Universität Berlin European Observatory on Health
More informationClinical Policy Bulletin: Hyperthermia in Cancer Therapy
Hyperthermia in Cancer Therapy Page 1 of 28 Aetna Better Health 2000 Market Street, Suite 850 Philadelphia, PA 19103 AETNA BETTER HEALTH Clinical Policy Bulletin: Hyperthermia in Cancer Therapy Number:
More informationCancer Survivorship Care
1113 Prog FOCUS BERGAMO.qxp 3-09-2013 10:22 Pagina 1 Menarini Foundation Symposia: 000 Focus on Rare Diseases: Cancer Survivorship Care Bergamo (Italy), November 14 th - 16 th, 2013 Organized by CLINICAL
More informationE UROPEAN PERSONAL INFORMATION
E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Work Address ARTURO CHITI Humanitas University, Via A. Manzoni 113, 20089 Rozzano (MI), Italy Nuclear Medicine Department, Humanitas Research
More informationHealthcare Management
5-7 May 2015 Gallagher Convention Centre, Midrand, Johannesburg, OFFICIAL CHARITY 2015 Healthcare Management Conference ALL REGISTRATION FEES FROM THE CONFERENCES WILL BE DONATED TO THE STEPS CHARITY 5
More informationHow do I find the best place to get treatment for my lymphoma?
Produced November 2010 Next revision due November 2012 How do I find the best place to get treatment for my lymphoma? Introduction Fortunately this is not a question that patients with cancers of the blood
More informationSalisbury Lung Cancer Service (1 of 5)
Salisbury Lung Cancer Service (1 of 5) i If you need this information in another language or medium (audio, large print, etc) please contact Customer Care on 0800 374 208 email: customercare@ salisbury.nhs.uk.
More informationGynaecological Cancers 2015
Gynaecological Cancers 2015 Annex D Epidemiology 1. It is estimated that there will be an increase in the incidence of gynaecological cancers by 2015. For example: a. The incidence of cervical cancer is
More informationBritish Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015
0116 250 2811 dawn.mckinley@uhl-tr.nhs.uk www.btog.org @BTOGORG British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015 BTOG s Aim BTOG is the multi-disciplinary group for professionals
More informationEUTHANASIA IN EUROPE FIRST EUROPEAN SYMPOSIUM ON EUTHANASIA AND ASSISTED SUICIDE EDINBURGH CONFERENCE CENTRE
CARENOTKILLING 6-8 SEPTEMBER 2012 FIRST EUROPEAN SYMPOSIUM ON EUTHANASIA AND ASSISTED SUICIDE EDINBURGH CONFERENCE CENTRE EUTHANASIA IN EUROPE WHERE HAVE WE COME FROM AND WHERE ARE WE GOING? CARENOTKILLING
More informationEORTC MELANOMA GROUP MEETING
EORTC MELANOMA GROUP MEETING April 29th-30th, 2016 MILAN - ITALY Istituto Europeo di Oncologia via Ripamonti 435, Milan Host AlessandroTestori Istituto Europeo di Oncologia, Milan, Italy Group Chair Caroline
More informationPRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology
PRODYNOV Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI Image Assisted Laser Therapy for Oncology Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI
More informationHow To Prepare A Meeting For A Health Care Conference
THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY EXECUTIVE SUMMARY 1. All patients in Lothian with thoracic malignancies should be discussed at designated times in pathway (see App
More informationSTRESA 31/03/11 RARE SOLID CANCERS: AN INTRODUCTION. 31 March - 1 April 2011 Stresa, Italy. Chairs: P.G. Casali, IT - G. Gatta, IT
ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA 31/03/11 RARE SOLID CANCERS: AN INTRODUCTION 31 March - 1 April 2011 Stresa, Italy Chairs: P.G. Casali, IT - G. Gatta, IT STRESA In collaboration with COURSE
More informationORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN
D International Symposium: Immunostimulatory monoclonal antibodies and immunomodulation: harvesting the crop Fundación Ramón Areces GENERAL INFORMATION DATES OCTOBER 18th 20th VENUE University of Navarra.
More informationA succesfull case of HIPEC in a peritoneal mesothelioma patient
A succesfull case of HIPEC in a peritoneal mesothelioma patient Firmino, NLJ¹²; Miranda, E¹³; Oliveira, DA ²; Lima, MBA ¹²; Diniz, AF ¹²; Gomes, GES ¹²; Azevedo, LW ¹²; Soares,MC¹²; Gomes, ASA³. ¹Pernambuco
More informationCytoreduction and Intraperitoneal Chemotherapy for the Management of Non-Gynecological Peritoneal Surface
J. Exp. Clin. Cancer Res., 22, 4, 2003 - Supplement Cytoreduction and Intraperitoneal Chemotherapy for the Management of Non-Gynecological Peritoneal Surface Malignancy Yan T.D., Esquivel J., Carmignani
More informationGynecologic Cancer in Women with Lynch Syndrome
Gynecologic Cancer in Women with Lynch Syndrome Sarah E. Ferguson, MD FRCSC Division of Gynecologic Oncology, Princess Margaret Hospital, University of Toronto June 11, 2013 Objective 1. To review the
More informationProfessional Managers Annual Conference Adding value to business schools Programme
Professional Managers Annual Conference Adding value to business schools Programme 3-4 December 2015, Regent s University London Professional Managers Annual Conference 2015 - Adding value to business
More informationPlease see the LUCADA data manual v3.1.3, available in the downloads section
National Lung Cancer Audit Frequently Asked Questions What dataset should be used? Please see the LUCADA data manual v3.1.3, available in the downloads section What does LUCADA stand for? LUCADA stands
More informationFAMILIAL CANCER ESO, CNIO AND NRCO CONFERENCE ON. 19-20 May 2016 Madrid, Spain. Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H.
INSIDE TRACK CONFERENCE ESO, CNIO AND NRCO CONFERENCE ON FAMILIAL CANCER 19-20 May 2016 Madrid, Spain Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H. Vasen, NL FOREWORD The ESO, CNIO and NRCO Conference
More informationCytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma
Original Article 291 Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma Grace HC Tan, 1 MBBS (London), MRCS (Edinburgh), Michelle Cheung, 1 MBBCh
More informationUnderstanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS foundationforwomenscancer.org Contents Introduction...1 CA 125................................... 1 The CA 125 Test...2 The Use of the CA
More informationGuideline for the Follow Up of Patients Following Treatment for Breast Cancer
Guideline for the Follow Up of Patients Following Treatment for Breast Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Page 1 of 6 1 Scope of the Guideline This guideline
More informationBristol Hospital Cancer Care Center 2015 Annual Report
Bristol Hospital Cancer Care Center 2015 Annual Report 2015 Annual Report Cancer Care Center At every point along the path, our team is there, keeping the focus on the most important team member - the
More informationMinimally Invasive Cardiac Surgery
3rd Annual Bakken Symposium Minimally Invasive Cardiac Surgery December 7 & 8, 2009 Mayo Auditorium, COURSE DIRECTORS: Kenneth K. Liao, MD, PhD James D. St. Louis, MD Presented by Department of Surgery
More informationONDON. Complications in Spine Surgery An International Educational Training Program. Course Chairmen: 5-6 June, 2015 London, UK
Complications in Spine Surgery An International Educational Training Program 5-6 June, 2015 London, UK Hilton London Paddington Hotel Course Chairmen: Professor Rune Hedlund, MD, PhD Choll Kim, MD, PhD
More informationPREPARING FOR YOUR STOMA REVERSAL
PREPARING FOR YOUR STOMA REVERSAL Information Leaflet Your Health. Our Priority. Page 2 of 6 Introduction- What you need to know As part of your bowel operation you may have had a temporary stoma formed.
More information